India’s CDMO Sector: Fund Managers Predict Long-Term Growth
By Business Desk
Fund managers see India’s CDMO sector poised for significant long-term expansion, driven by global supply chain shifts and enhanced local innovation and IP protection.
India’s Contract Development and Manufacturing Organization (CDMO) sector presents a significant long-term growth opportunity, according to fund managers like Mihir Vora of TRUST Mutual Fund. This optimistic outlook underscores a strategic shift in global pharmaceutical development, with India emerging as a pivotal hub.
Driving Factors Behind India’s CDMO Ascent
The sector’s robust potential is significantly bolstered by the prevailing China+1 strategy. This global trend encourages diversification of supply chains away from China, directly benefiting Indian manufacturing capabilities.
Furthermore, India is demonstrating increasing capabilities in innovation. This growing expertise allows the nation to contribute more substantially to the complex processes of drug development.
Enhanced intellectual property protection within India also plays a crucial role. This provides a more secure environment for sensitive pharmaceutical research and development, attracting international partners.
The establishment of strong partnerships with global pharmaceutical companies further cements India’s position. These collaborations are vital for knowledge transfer and market access.
Strategic Corporate Engagement
Multinational pharmaceutical firms are increasingly committing to the Indian market through long-term contracts. This commitment signals sustained confidence in India’s CDMO capabilities and its regulatory environment.
Many global players are also establishing dedicated manufacturing facilities within India. Such investments highlight the country’s expanding and solidified role in global drug development, making CDMO stocks particularly attractive for pharma investors.
The confluence of geopolitical strategies, local innovation, and robust international collaborations positions India’s CDMO sector for substantial and sustained expansion in the foreseeable future.